# FDA Inspection 1266065 - Robert Molpus - April 03, 2025

Source: https://www.keypedia.com/records/fda_inspections/robert-molpus/a3a7a1cc-83dc-432d-807c-b450bc9d442a
Source feed: FDA_Inspections

> FDA Inspection 1266065 for Robert Molpus on April 03, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266065
- Company Name: Robert Molpus
- Inspection Date: 2025-04-03
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266065 - 2025-04-03](https://www.keypedia.com/records/fda_inspections/robert-molpus/64f6ffe4-11f1-48ee-8ad9-7793f44735f0)
- [FDA Inspection 1127812 - 2020-08-10](https://www.keypedia.com/records/fda_inspections/robert-molpus/4b1a3c63-3198-49c3-b3c3-0540242a6e0e)
- [FDA Inspection 1039869 - 2018-01-26](https://www.keypedia.com/records/fda_inspections/robert-molpus/a9920e64-24d3-4466-903a-6a4e585fb717)

Company: https://www.keypedia.com/companies/robert-molpus/85c57cdc-e62c-46e2-83e4-a4c22ae846ad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c